10.1016/s2213-2600(20)30448-3 - Adjunctive host-directed therapies fo...

This document has been corrected

Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial

10.1016/s2213-2600(20)30448-3

Published Online: 2021-08-?

Journal: The Lancet Respiratory Medicine•Publisher: Elsevier BV

Authors: Bintou A Ahidjo•Gavin Churchyard•Katherine Fielding•Khatija Ahmed•Mboyo D T Vangu•Mohammed Rassool•Morongwe Likoti•Nishanee Arjun•Robert S Wallis•Sibuse Ginindza•Trevor Beattie•Vinodh A Edward

This document has been corrected

Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial

10.1016/s2213-2600(20)30448-3

Published Online: 2021-08-?

Journal: The Lancet Respiratory Medicine

NOW

2021-06-01•Erratum

Correction to Lancet Respir Med 2021; published online Feb 26. https://doi.org/10.1016/S2213-2600(20)30448-3

10.1016/s2213-2600(21)00204-6

* information provided by CrossRef

2021-06-01•Erratum

10.1016/s2213-2600(21)00204-6

* information provided by CrossRef

2021-08-?•Published

2021-06-01•Erratum

Correction to Lancet Respir Med 2021; published online Feb 26. https://doi.org/10.1016/S2213-2600(20)30448-3

10.1016/s2213-2600(21)00204-6

* information provided by CrossRef

This document has been corrected

Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial

10.1016/s2213-2600(20)30448-3

Published Online: 2021-08-?

Journal: The Lancet Respiratory Medicine•Publisher: Elsevier BV